Skip to main content

Page of 2 next disabled
and
  1. No Access

    Chapter and Conference Paper

    Experimental Therapy for Malignant Brain Tumors Using Genetically Engineered Herpes Simplex Virus Type 1

    We are exploring a novel experimental treatment for malignant brain tumors utilizing a genetically engineered, attenuated, replication-competent herpes simplex virus type 1 (HSV-1). Our previous studies demons...

    Toshihiro Mineta, Samuel D. Rabkin, Robert L. Martuza in Brain Tumor (1996)

  2. No Access

    Article

    Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

    We have created a double mutant of the herpes simplex virus (HSV) type 1 (termed G207) with favourable properties for treating human malignant brain tumours: replication–competence in glioblastoma cells (and o...

    Toshihiro Mineta, Samuel D. Rabkin, Takahito Yazaki, William D. Hunter in Nature Medicine (1995)

  3. No Access

    Article

    Inhibition of angiogenesis and growth of human non-malignant and malignant meningiomas by TNP-470

    Meningiomas are relatively common (22%) vascular brain tumors. 3–11% of meningiomas are malignant, and defy currently available therapy. Inhibition of neovascularization is one potential strategy for treating ...

    Takahito Yazaki, Yoshiaki Takamiya, Penelope C. Costello in Journal of Neuro-Oncology (1995)

  4. No Access

    Chapter

    Virus-Mediated Genetic Treatment of Rodent Gliomas

    The most common primary central nervous system neoplasm in adults is the malignant glioma. Approximately 5,000 new cases are diagnosed annually in the United States. This tumor has proven to be extremely refra...

    E. Antonio Chiocca, Julie K. Andersen, Yoshiaki Takamiya in Gene Therapeutics (1994)

  5. No Access

    Article

    Growth of human acoustic neuromas, neurofibromas and schwannomas in the subrenal capsule and sciatic nerve of the nude mouse

    To develop a reproducible in vivo model for the growth of human acoustic neuromas and neurofibromas, we implanted tumor specimens (6 acoustic neuromas; 4 neurofibromas; 3 schwannomas arising in skin and soft tiss...

    Jung Kyo Lee, Raymond A. Sobel, E. Antonio Chiocca, Tai S. Kim in Journal of Neuro-Oncology (1992)

  6. No Access

    Chapter

    Genetic Alterations of Nervous System Tumors

    The last decade has witnessed revolutionary advances in our understanding of the basic molecular changes associated with carcinogenesis in general and with nervous system tumorigenesis in particular. This repo...

    Robert L. Martuza in Biological Aspects of Brain Tumors (1991)

  7. No Access

    Article

    Photodynamic therapy is potentiated by Co60 and intratumoral injection of hematoporphyrin derivative

    Hematoporphyrin derivative injected directly into a subcutaneous rat glioma resulted in a significant greater tumor growth inhibition than hematoporphyrin derivative injected parenterally upon stimulation by l...

    Herwig Kostron, Mitchel R. Swartz, Robert L. Martuza in Journal of Neuro-Oncology (1988)

  8. No Access

    Article

    Genetic linkage of bilateral acoustic neurofibromatosis to a DNA marker on chromosome 22

    Bilateral acoustic neurofibromatosis (BANF) is a severe autosomal dominant disorder involving development of multiple tumours of the nervous system including meningiomas, gliomas, neurofibromas and particular...

    Guy A. Rouleau, Wladimir Wertelecki, Jonathan L. Haines, Wendy J. Hobbs in Nature (1987)

  9. No Access

    Article

    Loss of genes on chromosome 22 in tumorigenesis of human acoustic neuroma

    The application of recombinant DNA techniques has identified two fundamental mechanisms of tumorigenesis in man. The first involves a qualitative or quantitative change in an oncogene (see ref. 1 for review). ...

    Bernd R. Seizinger, Robert L. Martuza, James F. Gusella in Nature (1986)

Page of 2 next disabled